TOLCAPONE

TOLCAPONE was reported 352 times

TOLCAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXPOSURE TO LEAD 1 0.1429
1 CATASTROPHIC REACTION 2 0.0317
2 KLEPTOMANIA 2 0.0274
3 CERVICAL ROOT PAIN 1 0.0227
4 MICROGRAPHIA 1 0.0200
5 POLYRADICULONEUROPATHY 1 0.0192
6 PROGRESSIVE SUPRANUCLEAR PALSY 3 0.0149
7 ELECTROCARDIOGRAM LOW VOLTAGE 1 0.0132
8 CATHETER SITE DISCOMFORT 1 0.0125
9 DRUG CHEMICAL INCOMPATIBILITY 1 0.0122
10 NERVE CONDUCTION STUDIES ABNORMAL 2 0.0120
11 WRONG PATIENT 6 0.0120
12 APPLICATION SITE ECZEMA 1 0.0115
13 BASAL GANGLION DEGENERATION 1 0.0106
14 INFUSION SITE PAPULE 1 0.0105
15 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
16 PARKINSONIAN CRISIS 1 0.0097
17 APPLICATION SITE NECROSIS 1 0.0097
18 CATHETER SITE SCAB 1 0.0093
19 PATHOLOGICAL GAMBLING 15 0.0090
20 DOPAMINE DYSREGULATION SYNDROME 4 0.0090
21 HYPERKINESIA 19 0.0090
22 STOMA SITE ODOUR 2 0.0089
23 STOMA SITE INDURATION 1 0.0084
24 AKINESIA 16 0.0077
25 APPLICATION SITE NODULE 1 0.0073
26 JEALOUS DELUSION 2 0.0071
27 BASAL GANGLIA STROKE 1 0.0069
28 STOMA SITE INFLAMMATION 5 0.0067
29 DEEP BRAIN STIMULATION 4 0.0066
30 DRUG THERAPEUTIC INCOMPATIBILITY 1 0.0065
31 PIRIFORMIS SYNDROME 1 0.0059
32 CATHETER SITE ABSCESS 1 0.0057
33 STOMA SITE ULCER 1 0.0056
34 CATHETER SITE INDURATION 1 0.0052
35 SENSORY OVERLOAD 1 0.0051
36 BILIARY CIRRHOSIS 1 0.0050
37 MASKED FACIES 2 0.0049
38 STOMA SITE HYPERGRANULATION 3 0.0048
39 NEUROMUSCULAR BLOCKADE 1 0.0045
40 ILIOTIBIAL BAND SYNDROME 1 0.0044
41 INJECTION SITE GRANULOMA 1 0.0042
42 CEREBRAL MICROANGIOPATHY 1 0.0042
43 METATARSALGIA 1 0.0042
44 CAMPTOCORMIA 1 0.0042
45 STOMA SITE ABSCESS 1 0.0041
46 VITAMIN B6 DEFICIENCY 1 0.0041
47 SOMATIC DELUSION 1 0.0041
48 INCISION SITE DISCHARGE 1 0.0040
49 ENTERAL NUTRITION 2 0.0034
50 REGRESSIVE BEHAVIOUR 1 0.0034
51 INCISION SITE SWELLING 1 0.0033
52 ON AND OFF PHENOMENON 18 0.0032
53 PARAPROTEINAEMIA 1 0.0032
54 EUTHANASIA 1 0.0032
55 NODAL OSTEOARTHRITIS 1 0.0031
56 STOMA SITE INFECTION 4 0.0031
57 GASTRIC MUCOSA ERYTHEMA 1 0.0030
58 CATHETER SITE IRRITATION 1 0.0030
59 BACTERIAL PYELONEPHRITIS 1 0.0030
60 ENTEROSTOMY 1 0.0029
61 CUBITAL TUNNEL SYNDROME 1 0.0029
62 PATIENT-DEVICE INCOMPATIBILITY 2 0.0029
63 STOMA SITE DISCHARGE 8 0.0029
64 ANASTOMOTIC COMPLICATION 1 0.0029
65 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
66 APPLICATION SITE PUSTULES 1 0.0027
67 CATHETER SITE DISCHARGE 3 0.0027
68 DRUG EFFECT VARIABLE 3 0.0026
69 FAT TISSUE DECREASED 1 0.0026
70 FACTOR V LEIDEN MUTATION 1 0.0025
71 TRICUSPID VALVE DISEASE 1 0.0025
72 BRONCHITIS ACUTE 1 0.0025
73 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
74 MENINGEAL DISORDER 1 0.0025
75 EXCESSIVE GRANULATION TISSUE 2 0.0025
76 THERAPY REGIMEN CHANGED 1 0.0025
77 IMPULSE-CONTROL DISORDER 5 0.0024
78 PLEUROPERICARDITIS 1 0.0024
79 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
80 PARAPARESIS 4 0.0022
81 GAMBLING DISORDER 6 0.0022
82 INCISION SITE ERYTHEMA 1 0.0022
83 CSF TEST ABNORMAL 1 0.0020
84 INFUSION SITE ABSCESS 1 0.0020
85 PARKINSON'S DISEASE 5 0.0020
86 PLEURAL FIBROSIS 2 0.0020
87 PALLIATIVE CARE 3 0.0020
88 FLIGHT OF IDEAS 1 0.0019
89 B-CELL LYMPHOMA RECURRENT 1 0.0018
90 INFUSION SITE MASS 2 0.0018
91 STOMA SITE IRRITATION 1 0.0018
92 RENAL CELL CARCINOMA STAGE UNSPECIFIED 1 0.0018
93 GAZE PALSY 3 0.0018
94 SLEEP WALKING 1 0.0017
95 MEDICAL DEVICE SITE INFECTION 1 0.0016
96 PARKINSONIAN GAIT 1 0.0016
97 FEELING GUILTY 2 0.0015
98 THEFT 1 0.0015
99 INJECTION SITE NECROSIS 3 0.0015
100 STOMA SITE REACTION 1 0.0015
101 SOFT TISSUE NECROSIS 1 0.0015
102 INFUSION SITE INFLAMMATION 1 0.0014
103 TORTICOLLIS 3 0.0014
104 EYE ROLLING 1 0.0014
105 TONGUE PARALYSIS 1 0.0014
106 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
107 AORTIC VALVE SCLEROSIS 1 0.0014
108 FREEZING PHENOMENON 5 0.0013
109 INFUSION SITE INDURATION 2 0.0013
110 APRAXIA 2 0.0013
111 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
112 CATHETER SITE RELATED REACTION 1 0.0013
113 REFLUX OESOPHAGITIS 1 0.0013
114 GRIMACING 1 0.0013
115 BLOOD FIBRINOGEN INCREASED 1 0.0013
116 INCISION SITE HAEMORRHAGE 1 0.0012
117 KETONURIA 1 0.0012
118 URGE INCONTINENCE 1 0.0011
119 ABDOMINAL SEPSIS 1 0.0011
120 PLEUROTHOTONUS 1 0.0011
121 HYPERSEXUALITY 2 0.0011
122 FIBROMA 1 0.0011
123 STOMA SITE ERYTHEMA 2 0.0011
124 MICROANGIOPATHY 1 0.0011
125 INFUSION SITE NODULE 1 0.0010
126 ABDOMINAL WALL HAEMATOMA 2 0.0010
127 REDUCED FACIAL EXPRESSION 1 0.0010
128 STOMA COMPLICATION 1 0.0010
129 COMPULSIVE SHOPPING 2 0.0010
130 JOINT SPRAIN 1 0.0010
131 COGWHEEL RIGIDITY 1 0.0010
132 OEDEMA MUCOSAL 1 0.0010
133 BINGE EATING 1 0.0009
134 DEMENTIA WITH LEWY BODIES 1 0.0009
135 BLOOD FIBRINOGEN DECREASED 1 0.0009
136 ARTERIAL HAEMORRHAGE 1 0.0009
137 OSTEOCHONDROSIS 1 0.0009
138 GAMBLING 1 0.0009
139 DILATATION ATRIAL 1 0.0009
140 VOLVULUS 2 0.0008
141 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
142 APPLICATION SITE SCAR 1 0.0008
143 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
144 LIP DISCOLOURATION 1 0.0008
145 GLUCOSE URINE PRESENT 1 0.0008
146 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
147 CACHEXIA 4 0.0008
148 ABDOMINAL OPERATION 1 0.0008
149 GASTROENTERITIS NOROVIRUS 1 0.0008
150 CEREBRAL ATROPHY 3 0.0008
151 VITAMIN B12 DEFICIENCY 3 0.0007
152 INJECTION SITE NODULE 8 0.0007
153 BEZOAR 1 0.0007
154 SUDDEN ONSET OF SLEEP 1 0.0007
155 DYSKINESIA 28 0.0007
156 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
157 PULMONARY SEPSIS 1 0.0007
158 STOMA SITE PAIN 1 0.0007
159 COCCYDYNIA 1 0.0007
160 BRADYKINESIA 4 0.0007
161 HEPATITIS FULMINANT 2 0.0007
162 STOMA SITE HAEMORRHAGE 1 0.0006
163 VASCULAR RUPTURE 1 0.0006
164 NEOPLASM SKIN 1 0.0006
165 MEGACOLON 1 0.0006
166 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
167 POSTURE ABNORMAL 2 0.0006
168 POST PROCEDURAL HAEMATOMA 1 0.0006
169 AMMONIA INCREASED 3 0.0006
170 SPONDYLOLISTHESIS 1 0.0006
171 THYROIDECTOMY 1 0.0006
172 KYPHOSIS 1 0.0006
173 MITRAL VALVE DISEASE 1 0.0006
174 PRODUCT TAMPERING 1 0.0006
175 HYPERTENSIVE HEART DISEASE 1 0.0005
176 BLOOD IRON INCREASED 1 0.0005
177 CATHETER SITE INFECTION 2 0.0005
178 MYELOPATHY 1 0.0005
179 ATROPHY 1 0.0005
180 DIPLEGIA 1 0.0005
181 HYPERPHAGIA 2 0.0005
182 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
183 ORGAN FAILURE 2 0.0005
184 LIBIDO INCREASED 1 0.0005
185 MUSCLE CONTRACTURE 1 0.0005
186 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
187 PHYSICAL ASSAULT 1 0.0005
188 MYOPATHY 4 0.0005
189 CEREBELLAR SYNDROME 1 0.0005
190 CHOLESTATIC LIVER INJURY 1 0.0004
191 SMALL INTESTINE CARCINOMA 1 0.0004
192 PERFORMANCE STATUS DECREASED 2 0.0004
193 BILIRUBIN CONJUGATED INCREASED 1 0.0004
194 ESCHERICHIA BACTERAEMIA 1 0.0004
195 SPINAL COLUMN STENOSIS 2 0.0004
196 MUSCLE RIGIDITY 5 0.0004
197 PAINFUL RESPIRATION 1 0.0004
198 STARING 1 0.0004
199 SLOW SPEECH 1 0.0004
200 FLUID INTAKE REDUCED 2 0.0004
201 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
202 PELVIC FRACTURE 3 0.0004
203 COMPARTMENT SYNDROME 1 0.0004
204 EXFOLIATIVE RASH 1 0.0004
205 RADICULOPATHY 1 0.0004
206 YAWNING 1 0.0004
207 ABDOMINAL RIGIDITY 1 0.0004
208 GASTRIC PERFORATION 1 0.0004
209 HALLUCINATION 27 0.0004
210 PROCTITIS 1 0.0004
211 RESPIRATORY SYMPTOM 1 0.0004
212 PHARYNGEAL DISORDER 1 0.0003
213 FIBULA FRACTURE 1 0.0003
214 HYPOGLYCAEMIC COMA 1 0.0003
215 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
216 HYPERVENTILATION 2 0.0003
217 HYPOKINESIA 5 0.0003
218 RALES 2 0.0003
219 CRANIOCEREBRAL INJURY 1 0.0003
220 DYSCHEZIA 1 0.0003
221 FIBROSIS 1 0.0003
222 PORTAL HYPERTENSION 1 0.0003
223 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
224 SCOLIOSIS 2 0.0003
225 PNEUMONIA ASPIRATION 8 0.0003
226 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
227 DEVICE DISLOCATION 13 0.0003
228 QUALITY OF LIFE DECREASED 4 0.0003
229 PRODUCT ADMINISTRATION ERROR 6 0.0003
230 B-CELL LYMPHOMA 1 0.0003
231 MOTOR DYSFUNCTION 3 0.0003
232 MICTURITION DISORDER 1 0.0003
233 DEMENTIA 8 0.0003
234 DEVICE OCCLUSION 4 0.0003
235 HALLUCINATION, VISUAL 6 0.0003
236 DEVICE KINK 1 0.0003
237 CAROTID ARTERY OCCLUSION 1 0.0003
238 LEUKOENCEPHALOPATHY 1 0.0003
239 HEPATIC NECROSIS 1 0.0003
240 REHABILITATION THERAPY 1 0.0003
241 PANIC DISORDER 1 0.0003
242 DYSTONIA 5 0.0003
243 SENSATION OF HEAVINESS 1 0.0003
244 MUSCLE RUPTURE 1 0.0003
245 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
246 HOMICIDAL IDEATION 1 0.0002
247 DECUBITUS ULCER 2 0.0002
248 GOITRE 1 0.0002
249 DEMYELINATION 1 0.0002
250 CONGESTIVE CARDIOMYOPATHY 1 0.0002
251 FACIAL PARALYSIS 2 0.0002
252 INTENTIONAL DEVICE MISUSE 1 0.0002
253 WHEELCHAIR USER 1 0.0002
254 URINARY TRACT DISORDER 1 0.0002
255 PERSONALITY CHANGE 2 0.0002
256 YELLOW SKIN 1 0.0002
257 TIBIA FRACTURE 1 0.0002
258 COLITIS MICROSCOPIC 1 0.0002
259 PARALYSIS 3 0.0002
260 PULMONARY FIBROSIS 4 0.0002
261 INJECTION SITE HAEMATOMA 3 0.0002
262 PANCREATIC DISORDER 1 0.0002
263 FOOT OPERATION 1 0.0002
264 INFLAMMATORY MARKER INCREASED 1 0.0002
265 HYPERNATRAEMIA 1 0.0002
266 HYPERAMMONAEMIA 1 0.0002
267 SALIVARY HYPERSECRETION 2 0.0002
268 PETIT MAL EPILEPSY 1 0.0002
269 FEMORAL NECK FRACTURE 1 0.0002
270 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
271 SKIN NECROSIS 1 0.0002
272 RESTLESSNESS 7 0.0002
273 PARTIAL SEIZURES 1 0.0002
274 SPEECH DISORDER 10 0.0002
275 BLOOD LACTIC ACID INCREASED 1 0.0002
276 SUDDEN DEATH 2 0.0002
277 HALLUCINATION, AUDITORY 3 0.0002
278 MOVEMENT DISORDER 6 0.0002
279 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
280 DYSARTHRIA 7 0.0002
281 BLOOD BILIRUBIN INCREASED 5 0.0002
282 HYPERKERATOSIS 1 0.0002
283 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
284 GASTRIC ULCER HAEMORRHAGE 1 0.0002
285 STATUS EPILEPTICUS 2 0.0002
286 GENERALISED ERYTHEMA 1 0.0002
287 NEUTROPHILIA 1 0.0002
288 CARDIAC VALVE DISEASE 1 0.0002
289 MUSCLE TWITCHING 4 0.0002
290 HYPOVOLAEMIA 1 0.0002
291 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
292 PLEURISY 1 0.0002
293 MOBILITY DECREASED 12 0.0002
294 PLATELET COUNT ABNORMAL 1 0.0002
295 INGUINAL HERNIA 1 0.0002
296 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
297 TENSION 1 0.0002
298 EPILEPSY 5 0.0002
299 CYST 2 0.0002
300 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
301 MULTIPLE INJURIES 1 0.0002
302 SCREAMING 1 0.0002
303 FOREIGN BODY SENSATION IN EYES 1 0.0002
304 PRESCRIBED OVERDOSE 3 0.0002
305 INCOHERENT 1 0.0002
306 BRADYPHRENIA 1 0.0002
307 POLYP 1 0.0002
308 SOMNAMBULISM 1 0.0002
309 ABNORMAL BEHAVIOUR 6 0.0002
310 CARDIAC FAILURE ACUTE 1 0.0001
311 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
312 COLITIS ISCHAEMIC 1 0.0001
313 POSTOPERATIVE WOUND INFECTION 1 0.0001
314 ULCER HAEMORRHAGE 1 0.0001
315 DELIRIUM 5 0.0001
316 APPLICATION SITE REACTION 1 0.0001
317 PANIC REACTION 1 0.0001
318 LIVER FUNCTION TEST ABNORMAL 4 0.0001
319 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
320 APATHY 2 0.0001
321 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
322 HYDRONEPHROSIS 1 0.0001
323 HIP ARTHROPLASTY 2 0.0001
324 BOWEL MOVEMENT IRREGULARITY 1 0.0001
325 LIPASE INCREASED 1 0.0001
326 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
327 HAEMOLYSIS 1 0.0001
328 CONCUSSION 1 0.0001
329 COGNITIVE DISORDER 6 0.0001
330 AFFECTIVE DISORDER 1 0.0001
331 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
332 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
333 BLOOD ALBUMIN DECREASED 1 0.0001
334 CYSTITIS 4 0.0001
335 SENSORY DISTURBANCE 2 0.0001
336 MUSCLE DISORDER 1 0.0001
337 ENCEPHALOPATHY 3 0.0001
338 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
339 AGGRESSION 6 0.0001
340 CIRCULATORY COLLAPSE 2 0.0001
341 SCAR 2 0.0001
342 MULTI-ORGAN FAILURE 2 0.0001
343 PYELONEPHRITIS 1 0.0001
344 ORTHOSTATIC HYPOTENSION 2 0.0001
345 DEVICE USE ISSUE 2 0.0001
346 SPINAL OSTEOARTHRITIS 1 0.0001
347 METASTASES TO LIVER 2 0.0001
348 GRIP STRENGTH DECREASED 1 0.0001
349 LUNG INFILTRATION 1 0.0001
350 LYMPHOCYTE COUNT DECREASED 2 0.0001
351 JAUNDICE 3 0.0001
352 GOUT 2 0.0001
353 DRUG EFFECT DECREASED 6 0.0001
354 OROPHARYNGEAL DISCOMFORT 1 0.0001
355 GASTROINTESTINAL CARCINOMA 1 0.0001
356 RESTLESS LEGS SYNDROME 2 0.0001
357 RESPIRATORY DISTRESS 3 0.0001
358 UROSEPSIS 1 0.0001
359 NERVE COMPRESSION 1 0.0001
360 GRAND MAL CONVULSION 1 0.0001
361 PRODUCT DISTRIBUTION ISSUE 1 0.0001
362 ARTERIOSCLEROSIS 1 0.0001
363 SINUS BRADYCARDIA 1 0.0001
364 DYSSTASIA 3 0.0001
365 PARKINSONISM 1 0.0001
366 COELIAC DISEASE 1 0.0001
367 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
368 EMBEDDED DEVICE 1 0.0001
369 HAEMATOCRIT DECREASED 2 0.0001
370 SPINAL FRACTURE 2 0.0001
371 FEEDING DISORDER 2 0.0001
372 DRUG LEVEL DECREASED 1 0.0001
373 NEUTROPHIL COUNT INCREASED 1 0.0001
374 AGITATION 7 0.0001
375 HEAD INJURY 3 0.0001
376 INCONTINENCE 1 0.0001
377 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
378 FALL 31 0.0001
379 CONFUSIONAL STATE 15 0.0001
380 MUSCULOSKELETAL STIFFNESS 8 0.0001
381 TREMOR 15 0.0001
382 BLOOD PRESSURE DECREASED 6 0.0001
383 FOOT DEFORMITY 1 0.0001
384 TRANSAMINASES INCREASED 2 0.0001
385 HYPERTENSIVE CRISIS 1 0.0001
386 HEPATOTOXICITY 2 0.0001
387 SKIN INFECTION 1 0.0001
388 OCULAR DISCOMFORT 1 0.0001
389 DERMATITIS CONTACT 1 0.0001
390 HAEMATURIA 3 0.0001
391 SLEEP DISORDER 6 0.0001
392 BACTERAEMIA 1 0.0001
393 MYOCLONUS 1 0.0001
394 POLYNEUROPATHY 1 0.0001
395 BURSITIS 1 0.0001
396 CARDIOMEGALY 1 0.0001
397 TENDON RUPTURE 1 0.0001
398 GENERALISED OEDEMA 1 0.0001
399 ILEUS 1 0.0001
400 SECRETION DISCHARGE 1 0.0001
401 DERMATITIS ALLERGIC 1 0.0001
402 CARDIOVASCULAR DISORDER 2 0.0001
403 DEVICE DEPLOYMENT ISSUE 1 0.0001
404 HEPATITIS 2 0.0001
405 HAEMOGLOBIN DECREASED 8 0.0001
406 ERECTILE DYSFUNCTION 2 0.0001
407 UNRESPONSIVE TO STIMULI 2 0.0001
408 HIATUS HERNIA 1 0.0001
409 SUICIDAL IDEATION 7 0.0001
410 APPLICATION SITE ERYTHEMA 2 0.0001
411 BEDRIDDEN 1 0.0001
412 PULMONARY CONGESTION 1 0.0001
413 DISORIENTATION 3 0.0001
414 DYSPHAGIA 7 0.0001
415 IMPAIRED GASTRIC EMPTYING 1 0.0001
416 AKATHISIA 1 0.0001
417 ACUTE HEPATIC FAILURE 1 0.0001
418 PERIPHERAL COLDNESS 1 0.0001
419 RESPIRATORY ARREST 2 0.0001
420 ABNORMAL DREAMS 2 0.0001
421 FEELING COLD 2 0.0001
422 COORDINATION ABNORMAL 1 0.0001
423 MASS 1 0.0001
424 RED BLOOD CELL COUNT DECREASED 2 0.0001
425 HYPERSOMNIA 2 0.0001
426 SOMNOLENCE 14 0.0001
427 ANOSMIA 1 0.0001
428 SEPTIC SHOCK 3 0.0001
429 ACUTE MYOCARDIAL INFARCTION 2 0.0001
430 LIVER DISORDER 3 0.0001
431 DEVICE ISSUE 6 0.0001
432 HEPATIC FAILURE 2 0.0001
433 APHASIA 2 0.0001
434 CORONARY ARTERY DISEASE 2 0.0001
435 ECONOMIC PROBLEM 1 0.0001
436 PLEURAL EFFUSION 4 0.0001
437 DEVICE RELATED INFECTION 1 0.0001
438 URINARY TRACT INFECTION 11 0.0001
439 DELUSION 1 0.0001
440 NERVOUS SYSTEM DISORDER 2 0.0001
441 DRUG INTERACTION 10 0.0001
442 COMA 3 0.0001
443 OBESITY 1 0.0001
444 ABSCESS 1 0.0001
445 HIP FRACTURE 2 0.0001
446 PNEUMONIA 20 0.0001
447 MANIA 1 0.0001
448 COAGULOPATHY 1 0.0001
449 FUNGAL INFECTION 2 0.0001
450 URINARY RETENTION 2 0.0001
451 BLOOD UREA INCREASED 1 0.0001
452 HOSPITALISATION 9 0.0001
453 INFLAMMATION 3 0.0001
454 PARANOIA 1 0.0001
455 DEVICE DEFECTIVE 1 0.0001
456 DEVICE USE ERROR 2 0.0001
457 GAIT DISTURBANCE 11 0.0001
458 ISCHAEMIC STROKE 1 0.0001
459 GALLBLADDER DISORDER 1 0.0001
460 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
461 CEREBRAL HAEMORRHAGE 2 0.0001
462 GASTROINTESTINAL DISORDER 5 0.0001
463 DISTURBANCE IN ATTENTION 3 0.0001
464 LEUKOCYTOSIS 1 0.0001
465 HEPATIC STEATOSIS 1 0.0001
466 THINKING ABNORMAL 1 0.0001
467 MIDDLE INSOMNIA 1 0.0001
468 PHOTOPHOBIA 1 0.0001
469 FRACTURE 1 0.0001
470 DEPRESSION 12 0.0001
471 BLOOD URINE PRESENT 1 0.0001
472 INCREASED APPETITE 1 0.0001
473 POST PROCEDURAL COMPLICATION 1 0.0001
474 SEROTONIN SYNDROME 1 0.0001
475 GLAUCOMA 1 0.0001
476 CARDIAC FAILURE 4 0.0000
477 INTENTIONAL SELF-INJURY 1 0.0000
478 BODY TEMPERATURE INCREASED 1 0.0000
479 PERITONITIS 1 0.0000
480 RHABDOMYOLYSIS 2 0.0000
481 POOR QUALITY SLEEP 1 0.0000
482 PRURITUS GENERALISED 1 0.0000
483 MELAENA 1 0.0000
484 PULMONARY OEDEMA 2 0.0000
485 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
486 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
487 CHROMATURIA 1 0.0000
488 APPLICATION SITE PRURITUS 1 0.0000
489 MEMORY IMPAIRMENT 6 0.0000
490 SHOCK 1 0.0000
491 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
492 BLOOD PRESSURE FLUCTUATION 1 0.0000
493 LOCALISED INFECTION 1 0.0000
494 MENTAL IMPAIRMENT 1 0.0000
495 LUNG DISORDER 2 0.0000
496 LIVER INJURY 1 0.0000
497 ABASIA 1 0.0000
498 HYPOPHAGIA 1 0.0000
499 SKIN ULCER 1 0.0000
500 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
501 MUSCLE SPASMS 7 0.0000
502 GASTRITIS 1 0.0000
503 DEPRESSED MOOD 2 0.0000
504 BREAST CANCER FEMALE 1 0.0000
505 FEAR 1 0.0000
506 THROAT TIGHTNESS 1 0.0000
507 PALLOR 1 0.0000
508 TREATMENT NONCOMPLIANCE 2 0.0000
509 PROCEDURAL PAIN 1 0.0000
510 DRUG ABUSE 3 0.0000
511 MEDICATION ERROR 2 0.0000
512 SEPSIS 4 0.0000
513 HAEMOPTYSIS 1 0.0000
514 HYPONATRAEMIA 2 0.0000
515 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
516 INTENTIONAL DOSE OMISSION 1 0.0000
517 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
518 HYPOTENSION 7 0.0000
519 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
520 BALANCE DISORDER 3 0.0000
521 PSYCHOTIC DISORDER 1 0.0000
522 HYPOAESTHESIA 5 0.0000
523 SUICIDE ATTEMPT 2 0.0000
524 OEDEMA PERIPHERAL 4 0.0000
525 LIMB DISCOMFORT 1 0.0000
526 FEMUR FRACTURE 1 0.0000
527 METABOLIC ACIDOSIS 1 0.0000
528 LOSS OF CONSCIOUSNESS 4 0.0000
529 INTENTIONAL OVERDOSE 2 0.0000
530 ATRIAL FIBRILLATION 3 0.0000
531 DEEP VEIN THROMBOSIS 2 0.0000
532 IMPAIRED HEALING 1 0.0000
533 DEVICE DIFFICULT TO USE 2 0.0000
534 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
535 DYSPNOEA 17 0.0000
536 SYNCOPE 3 0.0000
537 ANGER 1 0.0000
538 HEPATIC ENZYME INCREASED 2 0.0000
539 GASTRIC DISORDER 1 0.0000
540 ABDOMINAL DISTENSION 3 0.0000
541 HYPOXIA 1 0.0000
542 LYMPHADENOPATHY 1 0.0000
543 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
544 CRYING 1 0.0000
545 CONSTIPATION 6 0.0000
546 C-REACTIVE PROTEIN INCREASED 1 0.0000
547 RESPIRATORY FAILURE 2 0.0000
548 INFLUENZA 3 0.0000
549 HEPATIC FUNCTION ABNORMAL 1 0.0000
550 DEATH 23 0.0000
551 DYSPNOEA EXERTIONAL 1 0.0000
552 INTESTINAL OBSTRUCTION 1 0.0000
553 UNEVALUABLE EVENT 2 0.0000
554 CONDITION AGGRAVATED 8 0.0000
555 INSOMNIA 7 0.0000
556 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
557 ABDOMINAL PAIN 6 0.0000
558 PLASMA CELL MYELOMA 1 0.0000
559 PARAESTHESIA 4 0.0000
560 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
561 EMOTIONAL DISTRESS 3 0.0000
562 DEVICE BREAKAGE 1 0.0000
563 LUNG NEOPLASM MALIGNANT 1 0.0000
564 OSTEOPOROSIS 1 0.0000
565 WITHDRAWAL SYNDROME 1 0.0000
566 OSTEOARTHRITIS 1 0.0000
567 DEVICE LEAKAGE 1 0.0000
568 MENTAL DISORDER 1 0.0000
569 MYOCARDIAL INFARCTION 4 0.0000
570 ADVERSE DRUG REACTION 2 0.0000
571 THERAPY NON-RESPONDER 1 0.0000
572 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
573 SKIN DISCOLOURATION 1 0.0000
574 WEIGHT DECREASED 6 0.0000
575 ARRHYTHMIA 1 0.0000
576 PULMONARY EMBOLISM 2 0.0000
577 ANAEMIA 4 0.0000
578 RASH ERYTHEMATOUS 1 0.0000
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
580 CONTUSION 2 0.0000
581 MALAISE 9 0.0000
582 DRY EYE 1 0.0000
583 LEUKOPENIA 1 0.0000
584 CELLULITIS 1 0.0000
585 CHEST DISCOMFORT 2 0.0000
586 ILLNESS 2 0.0000
587 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
588 HYPERTENSION 4 0.0000
589 OEDEMA 1 0.0000
590 DRUG DOSE OMISSION 3 0.0000
591 HAEMATOCHEZIA 1 0.0000
592 ARTHROPATHY 1 0.0000
593 NECK PAIN 1 0.0000
594 THROMBOCYTOPENIA 2 0.0000
595 BLISTER 1 0.0000
596 EYE PAIN 1 0.0000
597 CEREBROVASCULAR ACCIDENT 3 0.0000
598 MYALGIA 3 0.0000
599 FLATULENCE 1 0.0000
600 ANXIETY 5 0.0000
601 INCORRECT DOSE ADMINISTERED 4 0.0000
602 CONVULSION 1 0.0000
603 LETHARGY 1 0.0000
604 EYE IRRITATION 1 0.0000
605 SEIZURE 2 0.0000
606 CHILLS 2 0.0000
607 DIARRHOEA 11 0.0000
608 DISEASE PROGRESSION 2 0.0000
609 IRRITABILITY 1 0.0000
610 STOMATITIS 1 0.0000
611 VERTIGO 1 0.0000
612 INJECTION SITE ERYTHEMA 2 0.0000
613 ASTHENIA 6 0.0000
614 DEVICE EXPULSION 1 0.0000
615 AMNESIA 1 0.0000
616 PRODUCT DOSE OMISSION 1 0.0000
617 BLOOD CREATININE INCREASED 1 0.0000
618 DRUG INEFFECTIVE 20 0.0000
619 INFUSION RELATED REACTION 1 0.0000
620 RENAL FAILURE 2 0.0000
621 DEHYDRATION 2 0.0000
622 VOMITING 7 0.0000
623 PYREXIA 5 0.0000
624 COUGH 4 0.0000
625 INJURY 1 0.0000
626 DIZZINESS 7 0.0000
627 INFECTION 2 0.0000
628 UNDERDOSE 1 0.0000
629 PAIN IN EXTREMITY 4 0.0000
630 DIABETES MELLITUS 1 0.0000
631 INJECTION SITE SWELLING 1 0.0000
632 PERIPHERAL SWELLING 2 0.0000
633 BACK PAIN 3 0.0000
634 FATIGUE 10 0.0000
635 ARTHRITIS 1 0.0000
636 FEELING ABNORMAL 3 0.0000
637 CARDIAC FAILURE CONGESTIVE 1 0.0000
638 DRUG DEPENDENCE 2 0.0000
639 PROSTATE CANCER 1 0.0000
640 DRY MOUTH 1 0.0000
641 CARDIAC ARREST 1 0.0000
642 TREATMENT FAILURE 1 0.0000
643 COMPLETED SUICIDE 1 0.0000
644 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
645 RENAL IMPAIRMENT 1 0.0000
646 PAIN 7 0.0000
647 ADVERSE EVENT 1 0.0000
648 CARDIAC DISORDER 1 0.0000
649 BLOOD GLUCOSE INCREASED 2 0.0000
650 NEUROPATHY PERIPHERAL 1 0.0000
651 MIGRAINE 1 0.0000
652 OFF LABEL USE 9 0.0000
653 ALOPECIA 2 0.0000
654 NAUSEA 8 0.0000
655 FLUSHING 1 0.0000
656 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
657 SINUSITIS 1 0.0000
658 OVERDOSE 2 0.0000
659 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
660 ASTHMA 1 0.0000
661 MUSCULAR WEAKNESS 1 0.0000
662 PALPITATIONS 1 0.0000
663 JOINT SWELLING 1 0.0000
664 VISUAL IMPAIRMENT 1 0.0000
665 HYPERHIDROSIS 1 0.0000
666 DRY SKIN 1 0.0000
667 NEUTROPENIA 1 0.0000
668 ACUTE KIDNEY INJURY 1 0.0000
669 URTICARIA 1 0.0000
670 ABDOMINAL DISCOMFORT 1 0.0000
671 CHEST PAIN 1 0.0000
672 ABDOMINAL PAIN UPPER 1 0.0000
673 HEADACHE 3 0.0000
674 RASH 2 0.0000
675 WEIGHT INCREASED 1 0.0000
676 DECREASED APPETITE 1 0.0000
677 PRODUCT DOSE OMISSION ISSUE 1 0.0000
678 PRURITUS 1 0.0000
679 ARTHRALGIA 1 0.0000